If the quarter sales have improved, though unlikely, it should be the turn around in the sp in 3 weeks time, otherwise more downward pressure to $3.
The other catalyst that could hit this quarter is soft tissue last patient enrollment(more probable in the next qtr), though the vitiligo announcement didn't move the sp, and EB proof of concept.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.81 |
Change
0.040(2.26%) |
Mkt cap ! $128.9M | |||
| Open | High | Low | Value | Volume |
| $1.79 | $1.83 | $1.77 | $166.2K | 92.24K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17378 | $1.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.81 | 254 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2025 (20 minute delay) ? |
| AVH (ASX) Chart |